Targeted Therapeutics Market Research Report
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Targeted Therapeutics Market, By Type
7.1. Targeted Therapeutics Market, by Type, 2021-2030
7.1.1. Monoclonal Antibodies
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Small Molecule
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Targeted Therapeutics Market, By Application
8.1. Targeted Therapeutics Market, by Application, 2021-2030
8.1.1. Breast Cancer
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Colorectal Cancer
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Leukemia
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Lung Cancer
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Lymphoma
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Multiple Sclerosis
8.1.6.1. Market Revenue and Forecast (2016-2030)
8.1.7. Renal Cancer
8.1.7.1. Market Revenue and Forecast (2016-2030)
8.1.8. Wet Age-related Macular Degeneration
8.1.8.1. Market Revenue and Forecast (2016-2030)
8.1.9. Others (Ovarian Cancer, Fallopian Tube Cancer, Prostate Cancer, and Pancreatic Cancer)
8.1.9.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Targeted Therapeutics Market, By Distribution Channel
9.1. Targeted Therapeutics Market, by Distribution Channel, 2021-2030
9.1.1. Hospital Pharmacies
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Retail Pharmacies
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Online Pharmacies
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10.Global Targeted Therapeutics Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2016-2030)
Chapter 11. Company Profiles
11.1. Amgen, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. F. Hoffmann-La Roche Ltd.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AstraZeneca
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bristol-Myers Squibb Company
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Bayer AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Merck & Co., Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Novartis AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Pfizer Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers